Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIARFIN FLAS 2 MG LIOFILIZADO ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DIARFIN FLAS 2 MG LIOFILIZADO ORAL

Approved

STANDARD

DIARFIN FLAS 2 MG LIOFILIZADO ORAL

Laboratorios Cinfa S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 21, 2021
Approval ID: d0d7cbcf3e979197
Company: Laboratorios Cinfa S.A.
Type: Standard

Approval Details

Approval Id: d0d7cbcf3e979197
Drug Cima Aemps Name: DIARFIN FLAS 2 MG LIOFILIZADO ORAL
Register Number: 86472
Holder Company Name: Laboratorios Cinfa S.A.
Marketing Company Name: Laboratorios Cinfa S.A.
Authorization Date: 2021-12-21
Dosage Form: LIOFILIZADO ORAL
Dose: 2 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Cinfa S.A.

Active Ingredients

LOPERAMIDA HIDROCLORURO

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 21, 2021

Approval ID

d0d7cbcf3e979197

Type

Standard

Back to CIMA-AEMPS Approvals